✦ LIBER ✦

Proprotein convertase subtilisin–kexin type 9 is elevated in proteinuric subjects: Relationship with lipoprotein response to antiproteinuric treatment

✍ Scribed by Kwakernaak, Arjan J.; Lambert, Gilles; Slagman, Maartje C.J.; Waanders, Femke; Laverman, Gozewijn D.; Petrides, Francine; Dikkeschei, Bert D.; Navis, Gerjan; Dullaart, Robin P.F.

Book ID: 122972803
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 423 KB
Volume: 226
Category: Article
ISSN: 0021-9150
DOI: 10.1016/j.atherosclerosis.2012.11.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum levels of proprotein convertase su

Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor–independent pathways

✍ Jamie Cameron; Martin P. Bogsrud; Kristian Tveten; Thea Bismo StrØm; Kirsten Hol 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Relationship of proprotein convertase su

Relationship of proprotein convertase subtilisin-kexin type 9 levels with resistin in lean and obese subjects

✍ Arjan J. Kwakernaak; Gilles Lambert; Robin P.F. Dullaart 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Relationship of plasma apolipoprotein M

Relationship of plasma apolipoprotein M with proprotein convertase subtilisin–kexin type 9 levels in non-diabetic subjects

✍ Paul J.W.H. Kappelle; Gilles Lambert; Björn Dahlbäck; Lars Bo Nielsen; Robin P.F 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 153 KB

882 GENETIC VARIATIONS IN proprotein con

882 GENETIC VARIATIONS IN proprotein convertase subtilisin/kexin type 9 (PCSK9) GENE ARE ASSOCIATED WITH RESPONSE TO PEGYLATED INTERFERON/RIBAVIRIN IN HEPATITIS C VIRUS GENOTYPE 3-INFECTED PATIENTS

✍ Neukam, K.; Caruz, A.; Rivero-Juárez, A.; Labarga, P.; Márquez, M.; Real, L.M.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Plasma proprotein convertase subtilisin

Plasma proprotein convertase subtilisin kexin type 9 is not altered in subjects with impaired glucose metabolism and type 2 diabetes mellitus, but its relationship with non-HDL cholesterol and apolipoprotein B may be modified by type 2 diabetes mellitus: The CODAM study

✍ M.C.G.J. Brouwers; J.S. Troutt; M.M.J. van Greevenbroek; I. Ferreira; E.J. Feske 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 162 KB

RANDOMIZED, PARTIAL BLIND STUDY OF THE P

RANDOMIZED, PARTIAL BLIND STUDY OF THE PHARMACODYNAMICS, PHARMACOKINETICS AND SAFETY OF MULTIPLE SUBCUTANEOUS DOSES OF ALIROCUMAB, A FULLY HUMAN MONOCLONAL ANTIBODY TO PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9, ADMINISTERED EVERY 4 WEEKS ALONE OR IN COMBINATION WITH EZETIMIBE OR FENOFIBRATE IN HEALTHY SUBJECTS

✍ Rey, Jacques; Poitiers, Franck; Paehler, Tobias; Brunet, Aurelie; Pinquier, Jean 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 180 KB